GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (BOM:524396) » Definitions » Gross-Profit-to-Asset %

Biofil Chemicals & Pharmaceuticals (BOM:524396) Gross-Profit-to-Asset % : 3.99% (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Biofil Chemicals & Pharmaceuticals's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₹18.8 Mil. Biofil Chemicals & Pharmaceuticals's average Total Assets over the quarter that ended in Mar. 2024 was ₹470.8 Mil. Therefore, Biofil Chemicals & Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 3.99%.


Biofil Chemicals & Pharmaceuticals Gross-Profit-to-Asset % Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Gross-Profit-to-Asset % Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.16 8.79 9.65 10.42 6.44

Biofil Chemicals & Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.73 8.97 4.81 5.39 3.99

Competitive Comparison of Biofil Chemicals & Pharmaceuticals's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofil Chemicals & Pharmaceuticals's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Gross-Profit-to-Asset % falls into.



Biofil Chemicals & Pharmaceuticals Gross-Profit-to-Asset % Calculation

Biofil Chemicals & Pharmaceuticals's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=25.278/( (314.057+470.827)/ 2 )
=25.278/392.442
=6.44 %

Biofil Chemicals & Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=18.764/( (0+470.827)/ 1 )
=18.764/470.827
=3.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Biofil Chemicals & Pharmaceuticals Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description

Traded in Other Exchanges
Address
11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Headlines

No Headlines